Park Ha Biological Technology (BYAH) investor relations material

Management team and governance

• Principal executive offices are located in Wuxi, Jiangsu Province, China, with a U.S. agent for service in New York.

• The CEO is Xiaoqiu Zhang, who also serves as a director; other key officers include the CFO (Xiaoyan Zhu), CTO (Xinyu Li), and additional directors.

• Directors and officers are indemnified against losses except in cases of dishonesty, fraud, or willful neglect.

Offering details and pricing

• The registration statement is for the issuance of securities from time to time after the effective date, under a shelf registration (Form F-3).

• The offering may include senior and subordinated debt securities, warrants, rights, share purchase contracts, and units, with terms to be set by board resolution or supplemental indenture.

• Securities may be issued in one or more series, with an unlimited aggregate principal amount authorized.

Underwriters and syndicate

• Any underwriting agreement will provide for indemnification of the company and its officers and directors in certain cases.